Notice2022-09357
Interagency Coordinating Committee on the Validation of Alternative Methods; Notice of Public Webinar; Request for Public Input
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 2, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) will hold a public forum to share information and facilitate direct communication of ideas and suggestions from stakeholders. Interested persons may participate via the web meeting platform. Time will be set aside for questions and public statements on the topics discussed. Registration is required for both webinar viewing and oral statements. Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/ iccvamforum-2022.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 84 (Monday, May 2, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 84 (Monday, May 2, 2022)]
[Notices]
[Pages 25649-25650]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-09357]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee on the Validation of
Alternative Methods; Notice of Public Webinar; Request for Public Input
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) will hold a public forum to share
information and facilitate direct communication of ideas and
suggestions from stakeholders. Interested persons may participate via
the web meeting platform. Time will be set aside for questions and
public statements on the topics discussed. Registration is required for
both webinar viewing and oral statements. Information about the meeting
and registration are available at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2022">https://ntp.niehs.nih.gov/go/iccvamforum-2022</a>.
DATES:
Webinar: May 26-27, 2022, 10:00 a.m. to approximately 4:00 p.m. EDT
both days.
Registration for Webinar: April 11, 2022, until 4:00 p.m. EDT May
27, 2022.
Registration for Oral Statements: April 11, 2022, until 4:00 p.m.
EDT May 20, 2022.
Registration to view the webinar and present oral public statements
is required.
ADDRESSES: Webinar web page: <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2022">https://ntp.niehs.nih.gov/go/iccvamforum-2022</a>.
FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Acting
Director, NICEATM, email: <a href="/cdn-cgi/l/email-protection#d6b8bfb5b9bab3f8bdbab3bfb8a5a2a4b3a3b3a496b8bfbef8b1b9a0"><span class="__cf_email__" data-cfemail="aac4c3c9c5c6cf84c1c6cfc3c4d9ded8cfdfcfd8eac4c3c284cdc5dc">[email protected]</span></a>, telephone: (984)
287-3150.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM, a congressionally mandated committee, promotes
the development and validation of alternative testing strategies that
protect human health and the environment while replacing, reducing, or
refining animal use.
ICCVAM's goals include promotion of national and international
partnerships between governmental and nongovernmental groups, including
academia, industry, advocacy groups, and other key stakeholders. To
foster these partnerships ICCVAM convenes an annual public forum to
share information and facilitate direct communication of ideas and
suggestions from stakeholders (79 FR 25136).
This year's meeting will be held on May 26 and 27, 2022. Due to
restrictions on in-person gatherings amid ongoing public health
concerns, the public forum will be presented via webinar only. NICEATM
and ICCVAM members will give presentations on member agencies' current
activities related to the development and validation of alternative
test methods and approaches.
There will be opportunities for registered participants to ask
clarifying or follow-up questions of the ICCVAM members about their
presentations during the meeting. Instructions for submitting these
questions will be provided via email prior to the webinar. The agenda
will also include time for public oral statements relevant to the
ICCVAM mission and current activities
[[Page 25650]]
from participants who have registered to do so in advance.
Preliminary Agenda and Other Meeting Information: A preliminary
agenda will be posted by May 6 at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2022">https://ntp.niehs.nih.gov/go/iccvamforum-2022</a>. Interested individuals are encouraged to visit this
web page to stay abreast of the most current meeting information.
Webinar and Registration: This webinar is open to the public.
Registration for the webinar is required and is open from April 11,
2022, through 4:00 p.m. EDT on May 27, 2022 at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2022">https://ntp.niehs.nih.gov/go/iccvamforum-2022</a>. Interested individuals are
encouraged to visit this web page to stay abreast of the most current
meeting information. Registrants will receive instructions on how to
access and participate in the webinar in the email confirming their
registration.
Request for Oral or Written Public Statements: In addition to time
for clarifying or follow-up questions following scheduled
presentations, time will be allotted during the meeting for oral public
statements with associated slides on topics relevant to ICCVAM's
mission. Any participant registered for the webinar may ask clarifying
questions during the appropriate times in the agenda. The additional
registration is only required for those who wish to give separate
public statements. Written public statements on topics relevant to
ICCVAM's mission will also be accepted.
Separate registration for those wishing to provide oral public
statements is required and is open from April 11, 2022 through May 20,
2022 at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2022">https://ntp.niehs.nih.gov/go/iccvamforum-2022</a>. The number and
length of public statement presentations may be limited based on
available time. Submitters will be identified by their name and
affiliation and/or sponsoring organization, if applicable. Participants
registered to present oral public statements must email their statement
to <a href="/cdn-cgi/l/email-protection#f4bdb7b7a2b5b985819187809d9b9a87b49a9d919c87da9a9d9cda939b82"><span class="__cf_email__" data-cfemail="fdb4bebeabbcb08c88988e899492938ebd939498958ed3939495d39a928b">[email protected]</span></a> by May 20, 2022, to allow time for
review by NICEATM and ICCVAM and posting to the meeting page prior to
the forum. Persons presenting oral public statements will be contacted
to arrange the logistics of their presentations. If participants
registered to present oral public statements wish to use accompanying
slides and/or submit supplementary written material, they must email
these materials to <a href="/cdn-cgi/l/email-protection#7b3238382d3a360a0e1e080f121415083b15121e130855151213551c140d"><span class="__cf_email__" data-cfemail="94ddd7d7c2d5d9e5e1f1e7e0fdfbfae7d4fafdf1fce7bafafdfcbaf3fbe2">[email protected]</span></a> by May 20, 2022. This
deadline is to allow time for review by NICEATM and ICCVAM and posting
to the meeting page prior to the forum.
Written statements on topics relevant to ICCVAM's mission may be
submitted to support an oral public statement or as standalone
documents. These should be emailed to <a href="/cdn-cgi/l/email-protection#3178727267707c4044544245585e5f42715f585459421f5f58591f565e47"><span class="__cf_email__" data-cfemail="97ded4d4c1d6dae6e2f2e4e3fef8f9e4d7f9fef2ffe4b9f9feffb9f0f8e1">[email protected]</span></a> by
May 20, 2022. Public statements received prior to the May 20, 2022
deadline will be distributed to NICEATM and ICCVAM members before the
meeting. Written public statements received after the deadline may be
reviewed by NICEATM and ICCVAM at a future date.
Materials submitted to accompany oral public statements or
standalone written statements should include the submitters name,
affiliation (if any), mailing address, telephone, email, and sponsoring
organization (if any) with the document. National Toxicology Program
guidelines for public statements are at <a href="http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf">http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf</a>.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM and NICEATM: ICCVAM is an
interagency committee composed of representatives from 17 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability. ICCVAM also promotes the scientific validation and
regulatory acceptance of testing methods that more accurately assess
the safety and hazards of chemicals and products and replace, reduce,
or refine animal use.
The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes
ICCVAM as a permanent interagency committee of NIEHS and provides the
authority for ICCVAM involvement in activities relevant to the
development of alternative test methods. Additional information about
ICCVAM can be found at <a href="https://ntp.niehs.nih.gov/go/iccvam">https://ntp.niehs.nih.gov/go/iccvam</a>.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative test methods and strategies for
validation studies and technical evaluations. Additional information
about NICEATM can be found at <a href="https://ntp.niehs.nih.gov/go/niceatm">https://ntp.niehs.nih.gov/go/niceatm</a>.
Dated: April 12, 2022.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2022-09357 Filed 4-29-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 2, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.